Here's something you might be interested in.
Ask a Hipster — Advice you didn't know you needed
Big Screen — Movie commentary
Blurt — Music's inside track
Booze News — San Diego spirits
Classical Music — Immortal beauty
Classifieds — Free and easy
Cover Stories — Front-page features
Drinks All Around — Bartenders' drink recipes
Excerpts — Literary and spiritual excerpts
Feast! — Food & drink reviews
Feature Stories — Local news & stories
Fishing Report — What’s getting hooked from ship and shore
From the Archives — Spotlight on the past
Golden Dreams — Talk of the town
The Gonzo Report — Making the musical scene, or at least reporting from it
Letters — Our inbox
Movies@Home — Local movie buffs share favorites
Movie Reviews — Our critics' picks and pans
Musician Interviews — Up close with local artists
Neighborhood News from Stringers — Hyperlocal news
News Ticker — News & politics
Obermeyer — San Diego politics illustrated
Outdoors — Weekly changes in flora and fauna
Overheard in San Diego — Eavesdropping illustrated
Poetry — The old and the new
Reader Travel — Travel section built by travelers
Reading — The hunt for intellectuals
Roam-O-Rama — SoCal's best hiking/biking trails
San Diego Beer — Inside San Diego suds
SD on the QT — Almost factual news
Sheep and Goats — Places of worship
Special Issues — The best of
Street Style — San Diego streets have style
Surf Diego — Real stories from those braving the waves
Theater — On stage in San Diego this week
Tin Fork — Silver spoon alternative
Under the Radar — Matt Potter's undercover work
Unforgettable — Long-ago San Diego
Unreal Estate — San Diego's priciest pads
Your Week — Daily event picks
Local journalism may not get the cash
Soon-Shiong: obvious tightwad
Billionaire Patrick Soon-Shiong will fight the U.S. Patent and Trademark Office over legal fees of $78,000.
As denizens of San Diego and Los Angeles await the pending takeover of their cities’ respective newspapers by wealthy L.A. physician Patrick Soon-Shiong, speculation is rampant regarding the future direction of local journalism. But those hoping for a significant infusion of cash into the papers by the pharmaceutical billionaire could be in for a disappointment, judging by a dispute in federal court over a losing patent battle by Soon-Shiong’s NantKewst, Inc., a drug-development outfit with a lab in San Diego.
As reported by Law.com February 28, NantKwest is fighting against having to pay a paltry $78,000 in legal fees to the United States Patent and Trademark Office after federal courts upheld the denial of the firm’s patent claim for treating cancer with “natural killer cells.” The patent office had rejected the application on the grounds of “obviousness,” according to court records. Notes Law.com, “Section 145 of the Patent Act provides that the patent applicant must pay ‘all of the expenses’ of the district court proceeding regardless of outcome.” NantKest maintains the law is overly vague and will soon present its case to the full federal circuit court of appeals in Washington.
Meanwhile, a local anonymous ex-employee of NantWorks, Soon-Shiong’s umbrella organization that also has a San Diego branch, posted a mixed review on Glassdoor.com. “I worked at NantWorks full-time (More than a year),” said the report. “Pros: Most of the colleagues were great. Cons: Entire office was laid off unexpectedly.”
Responded NantWorks: “We know this is a difficult time for all of us and especially you. Our intent as an organization is to be as transparent as possible. Management evaluates the portfolio companies and determines which products and services will continue to drive our mission and vision of delivering next-generation therapeutic treatments and solutions to patients. Although you were not directly employed by NantWorks, we hope that you will keep us in mind as a future employer.”
Here's something you might be interested in.
Local journalism may not get the cash
Soon-Shiong: obvious tightwad
Local journalism may not get the cash
Soon-Shiong: obvious tightwad
Billionaire Patrick Soon-Shiong will fight the U.S. Patent and Trademark Office over legal fees of $78,000.
As denizens of San Diego and Los Angeles await the pending takeover of their cities’ respective newspapers by wealthy L.A. physician Patrick Soon-Shiong, speculation is rampant regarding the future direction of local journalism. But those hoping for a significant infusion of cash into the papers by the pharmaceutical billionaire could be in for a disappointment, judging by a dispute in federal court over a losing patent battle by Soon-Shiong’s NantKewst, Inc., a drug-development outfit with a lab in San Diego.
As reported by Law.com February 28, NantKwest is fighting against having to pay a paltry $78,000 in legal fees to the United States Patent and Trademark Office after federal courts upheld the denial of the firm’s patent claim for treating cancer with “natural killer cells.” The patent office had rejected the application on the grounds of “obviousness,” according to court records. Notes Law.com, “Section 145 of the Patent Act provides that the patent applicant must pay ‘all of the expenses’ of the district court proceeding regardless of outcome.” NantKest maintains the law is overly vague and will soon present its case to the full federal circuit court of appeals in Washington.
Meanwhile, a local anonymous ex-employee of NantWorks, Soon-Shiong’s umbrella organization that also has a San Diego branch, posted a mixed review on Glassdoor.com. “I worked at NantWorks full-time (More than a year),” said the report. “Pros: Most of the colleagues were great. Cons: Entire office was laid off unexpectedly.”
Responded NantWorks: “We know this is a difficult time for all of us and especially you. Our intent as an organization is to be as transparent as possible. Management evaluates the portfolio companies and determines which products and services will continue to drive our mission and vision of delivering next-generation therapeutic treatments and solutions to patients. Although you were not directly employed by NantWorks, we hope that you will keep us in mind as a future employer.”
Comments